| Primary information |
|---|
| ID | 16435 |
| Uniprot ID | P85661 |
| Description | FMRFamide-like neuropeptides 6 [Cleaved into- QQDSEVEREMM; KSAYMRF-amide 1 (AF8 1) (PF3 1); KSAYMRF-amide 2 (AF8 2) (PF3 2); KSAYMRF-amide 3 (AF8 3) (PF3 3); KSAYMRF-amide 4 (AF8 4) (PF3 4); KSAYMRF-amide 5 (AF8 5) (PF3 5); KSAYMRF-amide 6 (AF8 6) (PF3 6)] |
| Organism | Lucihormetica grossei |
| Txonomy | Caenorhabditis ; Peloderinae ; Rhabditidae ; Rhabditoidea ; Rhabditomorpha ; Rhabditina ; Rhabditida ; Chromadorea ; Nematoda ; Ecdysozoa ; Protostomia ; Bilateria ; Eumetazoa ; Metazoa ; Opisthokonta ; Eukaryota ; cellular organisms |
| Subcellular Location | secreted |
| Developmental Stage | Expressed from the comma stage of embryogenesis; during all larval stages; and in adults. |
| Similarity | Periviscerokinin family |
| Tissue Specificity | Each flp gene is expressed in a distinct set of neurons. Flp-6 is expressed in the ASE sensory neurons; AFD; ASG; PVT and I1 neurons. |
| Post Translational Modification | T11 Valine amide |
| Function | Myotropic activity |
| Length | 170 |
| Molecular Weight | 19 |
| Name | Periviscerokinin-2 |
| Sequence | GSSGLISMPRV |
| Sequence map | NA |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|